TRVN: Insiders vs. Shorts

The most recent short interest data was recently released for the 10/31/2016 settlement date, and Trevena Inc ( TRVN) is one of the most shorted stocks of the Russell 3000, based on 7.01 "days to cover" versus the median component at 6.43. There are a number of ways to look at short data, but one metric that we find particularly useful is the "days to cover" because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then divided by the average daily volume, to express the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

Ten Bargains You Can Buy Cheaper Than The Insiders Did »

In the case of Trevena Inc ( TRVN), the total short interest at the 10/31/2016 settlement date was 1,804,274 shares, which compares to the average daily trading volume of just 257,333 shares, for a "days to cover" ratio of 7.01.

When short sellers eventually cover their positions, by definition there must be buying activity because a share that is currently sold short must be purchased to be covered. At the present levels of short interest, if from this point forward every single TRVN share traded represented a short position being closed, then at the average daily volume of 257,333 shares it would only be during the 8th trading day that every short position would be closed.

So it would stand to reason that should some unexpectedly good news come out, and short sellers did not have 8 days of patience but instead wanted to cover their short positions very suddenly, that situation could result in sending the stock higher until the higher price produces enough sellers to generate the necessary volume to close out those positions quickly.

If you liked this article you might like

3 Beaten-Down Biotechs That Should Head Up

Biotech Movers: Aratana Offering Priced Below Market, Shares Fall

Endo international, AngioDynamics Lead Biotech Movers

Trevena, Synergy Lead Biotech Movers